CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.36%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$3.74B
AUM Growth
-$335M
(-8.2%)
Cap. Flow
-$611M
Cap. Flow
% of AUM
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
21.69%
Holding
676
New
53
Increased
215
Reduced
238
Closed
121
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$118M |
| 2 |
Intel
INTC
|
$62.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$26.7M |
| 4 |
Clorox
CLX
|
$25.8M |
| 5 |
TJX Companies
TJX
|
$24.1M |
Top Sells
| 1 |
Amgen
AMGN
|
$107M |
| 2 |
Apple
AAPL
|
$71.8M |
| 3 |
Travelers Companies
TRV
|
$27.6M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$27.4M |
| 5 |
American Express
AXP
|
$26.9M |
Sector Composition
| 1 | Healthcare | 28.7% |
| 2 | Financials | 10.88% |
| 3 | Technology | 9.78% |
| 4 | Communication Services | 9.12% |
| 5 | Consumer Staples | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ecolab
ECL
$77.8B
| $4M | 0.11% |
34,959
+29,033
| +490% | +$3.32M |
|
|
RHT
202
DELISTED
Red Hat Inc
RHT
| $3.98M | 0.11% |
47,999
-1,265
| -3% | -$105K |
|
203
Synchrony
SYF
$28.1B
| $3.93M | 0.11% |
+129,312
| New | +$3.93M |
|
204
Halozyme
HALO
$8.61B
| $3.82M | 0.1% |
220,600
+91,000
| +70% | +$1.58M |
|
205
Brookfield
BN
$98.5B
| $3.82M | 0.1% |
230,885
-284,739
| -55% | -$4.71M |
|
206
Lowe's Companies
LOW
$151B
| $3.82M | 0.1% |
50,264
-125,408
| -71% | -$9.54M |
|
207
Insmed
INSM
$30.2B
| $3.79M | 0.1% |
208,800
+60,000
| +40% | +$1.09M |
|
|
BLUE
208
DELISTED
bluebird bio
BLUE
| $3.74M | 0.1% |
4,493
+1,081
| +32% | +$899K |
|
|
ACHN
209
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $3.72M | 0.1% |
344,300
| – | – |
|
210
Colgate-Palmolive
CL
$68.9B
| $3.71M | 0.1% |
55,703
-320,457
| -85% | -$21.3M |
|
211
Ford
F
$46.6B
| $3.64M | 0.1% |
258,600
+20,417
| +9% | +$288K |
|
212
Ross Stores
ROST
$49.6B
| $3.64M | 0.1% |
67,614
+4,605
| +7% | +$248K |
|
|
MRTX
213
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.63M | 0.1% |
115,000
+8,000
| +7% | +$253K |
|
214
Caterpillar
CAT
$197B
| $3.62M | 0.1% |
53,303
-168,453
| -76% | -$11.4M |
|
215
Vanguard Large-Cap ETF
VV
$44.5B
| $3.6M | 0.1% |
38,590
-6,185
| -14% | -$577K |
|
216
Xylem
XYL
$34.2B
| $3.59M | 0.1% |
98,416
-106,571
| -52% | -$3.89M |
|
|
NBL
217
DELISTED
Noble Energy, Inc.
NBL
| $3.59M | 0.1% |
109,033
+13,282
| +14% | +$437K |
|
|
RXDX
218
DELISTED
Ignyta, Inc.
RXDX
| $3.59M | 0.1% |
+267,500
| New | +$3.59M |
|
219
Credicorp
BAP
$20.2B
| $3.57M | 0.1% |
36,700
+18,600
| +103% | +$1.81M |
|
|
ACOR
220
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $3.51M | 0.09% |
683
+42
| +7% | +$216K |
|
221
Enanta Pharmaceuticals
ENTA
$192M
| $3.5M | 0.09% |
+106,000
| New | +$3.5M |
|
222
Teva Pharmaceuticals
TEVA
$21.5B
| $3.48M | 0.09% |
52,993
-6,000
| -10% | -$394K |
|
223
Fossil Group
FOSL
$174M
| $3.43M | 0.09% |
93,881
+59,005
| +169% | +$2.16M |
|
224
US Bancorp
USB
$75.8B
| $3.41M | 0.09% |
79,921
-265,721
| -77% | -$11.3M |
|
225
Ultragenyx Pharmaceutical
RARE
$3.09B
| $3.4M | 0.09% |
30,280
+4,000
| +15% | +$449K |
|